Compare Globus Medical Inc. Class A Common Stock (GMED) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Wayfair Inc — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Wayfair Inc trades at $104.22 (market cap $14.35B). The key difference: Wayfair Inc is the larger of the two by market cap, and Wayfair Inc is trading nearer its 52-week high, Globus Medical Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Wayfair Inc for 8 Days on average.
| GMED | W | |
|---|---|---|
Market Cap | $10.25B | $14.35B |
Volume | 1,059,528 | 2,196,186 |
Sector | Health | Consumer Cyclical |
52-Week High | $96.82 | $119.05 |
52-Week Low | $58.33 | $57.40 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $9.76B | $16.69B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Wayfair (W) trades at $107.99, up 1.74% today, with bullish technical signals from moving averages and a consensus price target of $114.13. The company shows strong revenue growth with $12.46B in 2025, though negative net income margins persist. Recent developments include the launch of 'Wayfair Delivers' brand platform and upcoming Q3 2026 earnings release on November 4, 2026.
The outlook remains cautiously optimistic with analyst support (54% buy ratings) and technical momentum, but profitability challenges and high debt-to-asset ratio of 95.11% present significant risks. The stock's current position near resistance at $108 suggests potential for breakout if Q3 earnings beat expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
